# Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients

> **NCT00482287** · PHASE2 · WITHDRAWN · sponsor: **Meditor Pharmaceuticals Ltd.**

## Conditions studied

- Hypotension
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** MTR105

## Key facts

- **NCT ID:** NCT00482287
- **Lead sponsor:** Meditor Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Site did not recruit any patients
- **Last updated:** 2015-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482287, "Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00482287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*